Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New blood thinner combo tested in heart procedure

NCT ID NCT00508924

First seen Jan 07, 2026 · Last updated Apr 29, 2026 · Updated 17 times

Summary

This study tested three different doses of a blood thinner called argatroban, given with standard drugs (clopidogrel and aspirin), in 140 patients with stable coronary artery disease or unstable angina who needed a procedure to open blocked heart arteries. The goal was to see how well argatroban prevents blood clots and bleeding compared to the usual blood thinner, heparin. The study was completed and focused on safety and effectiveness during and after the procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Study site

    Aalst, Belgium

  • Study site

    Bad Nauheim, Germany

  • Study site

    Cologne, Germany

  • Study site

    Dachau, Germany

  • Study site

    Düren, Germany

  • Study site

    Frankfurt, Germany

  • Study site

    Halle, Germany

  • Study site

    Mainz, Germany

Conditions

Explore the condition pages connected to this study.